Related Experiment Videos
Packaging cells for avian leukosis virus-based vectors with various host ranges
F L Cosset1, C Ronfort, R M Molina
1Centre de Génétique Moléculaire et Cellulaire, INRA, CNRS UMR106, Université Claude Bernard Lyon-I, Villerbanne, France.
Journal of Virology
|September 1, 1992
Summary
Researchers developed new packaging cells for avian leukosis virus (ALV). These cells produce helper-free ALV particles with reporter genes and specific envelope types (A, B, C, E), enabling tailored ALV studies.
Area of Science:
- * Virology
- * Molecular Biology
- * Genetics
Background:
- * The Haydée semipackaging cell line previously established produces avian leukosis virus (ALV) gag and pol proteins.
- * Development of packaging cell lines is crucial for producing replication-defective viral vectors.
Purpose of the Study:
- * To construct novel packaging cell lines expressing specific avian leukosis virus envelope (env) subgroups.
- * To generate helper-free ALV particles encoding the lacZ reporter gene with defined env specificities (A, B, C, E).
- * To investigate the influence of env subgroup and target cell type on recombinant lacZ virus titers.
Main Methods:
- * Utilized the established Haydée semipackaging cell line.
- * Constructed new packaging cells by introducing specific ALV env genes.
- * Produced recombinant ALV particles carrying the lacZ reporter gene.
- * Determined viral titers using appropriate assays.
Main Results:
- * Successfully generated packaging cells expressing ALV env subgroups B, C, and E.
- * Produced helper-free ALV particles containing the lacZ reporter gene and specific env subgroups (A, B, C, E).
- * Demonstrated that the titers of the recombinant lacZ virus are dependent on the env subgroup and the target avian cell type.
Conclusions:
- * The developed packaging cell lines provide a versatile system for producing specific ALV vectors.
- * This system facilitates the study of ALV envelope tropism and gene transfer efficiency.
- * Findings highlight the importance of env subgroup and target cell interactions in ALV-based gene delivery.